Corteva, Inc. $CTVA Shares Acquired by Chilton Capital Management LLC

Chilton Capital Management LLC grew its stake in Corteva, Inc. (NYSE:CTVA) by 18.1% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 445,350 shares of the company’s stock after acquiring an additional 68,380 shares during the period. Chilton Capital Management LLC owned about 0.07% of Corteva worth $30,119,000 as of its most recent filing with the SEC.

Other hedge funds have also recently made changes to their positions in the company. Norges Bank purchased a new stake in Corteva in the second quarter valued at approximately $434,220,000. Pacer Advisors Inc. grew its stake in shares of Corteva by 4,007.1% in the third quarter. Pacer Advisors Inc. now owns 2,442,177 shares of the company’s stock valued at $165,164,000 after buying an additional 2,382,715 shares in the last quarter. WCM Investment Management LLC raised its holdings in shares of Corteva by 29.6% in the 2nd quarter. WCM Investment Management LLC now owns 9,044,706 shares of the company’s stock valued at $672,836,000 after buying an additional 2,066,519 shares during the period. Marshall Wace LLP raised its holdings in shares of Corteva by 1,365.9% in the 2nd quarter. Marshall Wace LLP now owns 1,809,764 shares of the company’s stock valued at $134,882,000 after buying an additional 1,686,309 shares during the period. Finally, National Pension Service lifted its stake in Corteva by 148.4% during the 2nd quarter. National Pension Service now owns 2,454,601 shares of the company’s stock worth $182,941,000 after acquiring an additional 1,466,268 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

Corteva stock opened at $72.60 on Tuesday. The company has a current ratio of 1.58, a quick ratio of 1.07 and a debt-to-equity ratio of 0.07. The company has a fifty day simple moving average of $67.43 and a 200-day simple moving average of $68.33. The stock has a market cap of $49.06 billion, a P/E ratio of 31.03, a price-to-earnings-growth ratio of 1.82 and a beta of 0.74. Corteva, Inc. has a 12-month low of $53.40 and a 12-month high of $77.41.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, November 4th. The company reported ($0.23) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.49) by $0.26. The company had revenue of $2.62 billion for the quarter, compared to analysts’ expectations of $2.47 billion. Corteva had a return on equity of 9.37% and a net margin of 9.19%.Corteva’s quarterly revenue was up 6.5% on a year-over-year basis. During the same period last year, the firm earned ($0.49) earnings per share. Equities analysts expect that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, December 15th. Investors of record on Monday, December 1st were paid a dividend of $0.18 per share. The ex-dividend date was Monday, December 1st. This represents a $0.72 annualized dividend and a yield of 1.0%. Corteva’s payout ratio is presently 30.77%.

Wall Street Analysts Forecast Growth

CTVA has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft cut their price target on shares of Corteva from $90.00 to $85.00 and set a “buy” rating on the stock in a research note on Thursday, November 6th. UBS Group cut their target price on shares of Corteva from $85.00 to $81.00 and set a “buy” rating on the stock in a research note on Thursday, October 30th. KeyCorp reiterated a “sector weight” rating on shares of Corteva in a report on Friday, October 3rd. BNP Paribas Exane boosted their price target on shares of Corteva from $70.00 to $72.00 and gave the stock a “neutral” rating in a research note on Monday, November 17th. Finally, Wolfe Research increased their price objective on Corteva from $80.00 to $81.00 and gave the company an “outperform” rating in a research note on Friday, January 16th. Two analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $79.47.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.